Literature DB >> 17620784

Favorable responses to acute and chronic exercise in McArdle patients.

José L Maté-Muñoz1, Maria Moran, Margarita Pérez, Carolina Chamorro-Viña, Félix Gómez-Gallego, Catalina Santiago, Luis Chicharro, Carl Foster, Gisela Nogales-Gadea, Juan C Rubio, Antoni L Andreu, Miguel A Martín, Joaquín Arenas, Alejandro Lucia.   

Abstract

OBJECTIVE: This study reports acute exercise responses in a large (N = 46) series of patients with McArdle disease and responses to exercise training in a smaller (n = 9) set of patients.
DESIGN: Patients were studied during both incremental and steady-state cycle ergometer exercise, using cardiopulmonary testing, and the patients were compared with age- and gender-matched controls.
SETTING: The study was performed in a university setting (clinical exercise physiology laboratory). PARTICIPANTS: The 46 patients showed common features of McArdle disease. They were definitively diagnosed by histochemistry, biochemistry, and/or molecular genetic analysis. The 46 controls were healthy, sedentary individuals. INTERVENTION: Nine patients were studied before and after an 8-month supervised aerobic exercise training program (including five weekly sessions of walking and/or cycling exercise with a duration no greater than 60 minutes). MAIN OUTCOME MEASUREMENTS: The main indicators of exercise capacity that we measured were peak power output, peak oxygen uptake (VO2peak), and ventilatory threshold (VT).
RESULTS: Exercise capacity (peak power output, 35% control; VO2peak, 44% control; VT, 66% control) was markedly depressed in the patients. The patients who trained improved peak power output (25%), VO2peak (44%), and VT (27%), with no evidence of negative outcomes from training. Although not achieving normal values, the response to training put the patients into the lower limit of normal controls.
CONCLUSIONS: Under carefully controlled conditions, patients with McArdle disease may perform acute exercise safely, and they may respond favorably to training. This may offer an additional therapeutic option to help normalize the lifestyles of these patients.

Entities:  

Mesh:

Year:  2007        PMID: 17620784     DOI: 10.1097/JSM.0b013e3180f6168c

Source DB:  PubMed          Journal:  Clin J Sport Med        ISSN: 1050-642X            Impact factor:   3.638


  25 in total

Review 1.  Myopathies Related to Glycogen Metabolism Disorders.

Authors:  Mark A Tarnopolsky
Journal:  Neurotherapeutics       Date:  2018-10       Impact factor: 7.620

2.  Muscle molecular adaptations to endurance exercise training are conditioned by glycogen availability: a proteomics-based analysis in the McArdle mouse model.

Authors:  Carmen Fiuza-Luces; Alejandro Santos-Lozano; Francisco Llavero; Rocío Campo; Gisela Nogales-Gadea; Jorge Díez-Bermejo; Carlos Baladrón; África González-Murillo; Joaquín Arenas; Miguel A Martín; Antoni L Andreu; Tomàs Pinós; Beatriz G Gálvez; Juan A López; Jesús Vázquez; José L Zugaza; Alejandro Lucia
Journal:  J Physiol       Date:  2018-02-14       Impact factor: 5.182

Review 3.  McArdle disease: a unique study model in sports medicine.

Authors:  Alfredo Santalla; Gisela Nogales-Gadea; Niels Ørtenblad; Astrid Brull; Noemi de Luna; Tomàs Pinós; Alejandro Lucia
Journal:  Sports Med       Date:  2014-11       Impact factor: 11.136

4.  Low versus high carbohydrates in the diet of the world-class athlete: insights from McArdle's disease.

Authors:  Gisela Nogales-Gadea; Alfredo Santalla; Joaquín Arenas; Miguel A Martín; María Morán; Alejandro Lucia
Journal:  J Physiol       Date:  2017-05-01       Impact factor: 5.182

5.  The pathogenomics of McArdle disease--genes, enzymes, models, and therapeutic implications.

Authors:  Gisela Nogales-Gadea; Alfredo Santalla; Astrid Brull; Noemi de Luna; Alejandro Lucia; Tomàs Pinós
Journal:  J Inherit Metab Dis       Date:  2014-07-23       Impact factor: 4.982

Review 6.  Rodent models for resolving extremes of exercise and health.

Authors:  Fleur C Garton; Kathryn N North; Lauren G Koch; Steven L Britton; Gisela Nogales-Gadea; Alejandro Lucia
Journal:  Physiol Genomics       Date:  2015-09-22       Impact factor: 3.107

7.  Excessive skeletal muscle recruitment during strenuous exercise in McArdle patients.

Authors:  Dale E Rae; Timothy D Noakes; Alejandro F San Juan; Margarita Pérez; Gisela Nogales-Gadea; Jonatan R Ruiz; María Morán; Miguel A Martín; Antoni L Andreu; Joaquín Arenas; Alejandro Lucia
Journal:  Eur J Appl Physiol       Date:  2010-08-04       Impact factor: 3.078

Review 8.  Treatment Opportunities in Patients With Metabolic Myopathies.

Authors:  Mette Cathrine Ørngreen; John Vissing
Journal:  Curr Treat Options Neurol       Date:  2017-09-21       Impact factor: 3.598

9.  Myophosphorylase deficiency (McArdle disease) in a patient with normal pregnancy and normal pregnancy outcome.

Authors:  Warwick Giles; Catherine Maher
Journal:  Obstet Med       Date:  2011-07-26

10.  Clinical utility gene card for McArdle disease.

Authors:  Rhonda L Taylor; Mark Davis; Emma Turner; Astrid Brull; Tomás Pinos; Macarena Cabrera; Kristen J Nowak
Journal:  Eur J Hum Genet       Date:  2018-01-25       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.